| 10266532 |
Tricyclic modulators of TNF signaling |
Eric C. Breinlinger, Phil B. Cox, Justin D. Dietrich, Kristine E. Frank, Michael Friedman +10 more |
2019-04-23 |
$346,154,000 |
| 9012651 |
TRPV3 modulators |
Bruce Clapham, Phil B. Cox, Michael J. Dart, Arthur Gomtsyan, Tammie K. Jinkerson +7 more |
2015-04-21 |
$538,936,000 |
| 8772499 |
TRPV3 modulators |
Erol K. Bayburt, Bruce Clapham, Phil B. Cox, Jerome F. Daanen, Michael J. Dart +5 more |
2014-07-08 |
$130,605,000 |
| 8772500 |
TRPV3 modulators |
Erol K. Bayburt, Bruce Clapham, Phil B. Cox, Jerome F. Daanen, Michael J. Dart +4 more |
2014-07-08 |
$130,605,000 |
| 8609692 |
TRPV1 antagonists |
Arthur Gomtsyan, Erol K. Bayburt, Jun Chen, Stanley DiDomenico, Jerome F. Daanen +5 more |
2013-12-17 |
$84,666,000 |
| 8604053 |
TRPV1 antagonists |
Arthur Gomtsyan, Eric A. Voight, Erol K. Bayburt, Jun Chen, Jerome F. Daanen +5 more |
2013-12-10 |
$237,163,000 |
| 8487116 |
Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor |
Arthur Gomtsyan, Erol K. Bayburt, John R. Koenig, Chih-Hung Lee, Kirill A. Lukin +4 more |
2013-07-16 |
$103,995,000 |
| 8440691 |
Tetrahydroquinolinyl compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof |
Arthur Gomtsyan, Erol K. Bayburt, Chih-Hung Lee, Brian S. Brown, Tammie K. Jinkerson +3 more |
2013-05-14 |
$464,317,000 |
| 8350083 |
Antagonists of the TRPV1 receptor and uses thereof |
Arthur Gomtsyan, Jerome F. Daanen, Erol K. Bayburt, Chih-Hung Lee, Steven P. Latshaw |
2013-01-08 |
|
| 8338603 |
TRPV1 antagonists |
Arthur Gomtsyan, Erol K. Bayburt, Jerome F. Daanen, Michael E. Kort |
2012-12-25 |
|
| 8247413 |
Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor |
Chih-Hung Lee, Erol K. Bayburt, Stanley DiDomenico, Irene Drizin, Arthur Gomtsyan +5 more |
2012-08-21 |
$36,229,000 |
| 8232309 |
Prodrugs of compounds that inhibit TRPV1 receptor |
Arthur Gomtsyan, Erol K. Bayburt, John R. Koenig, Kennan C. Marsh, Chih-Hung Lee +3 more |
2012-07-31 |
$42,316,000 |
| 8084616 |
TRPV1 antagonists |
Arthur Gomtsyan, Erol K. Bayburt, Jerome F. Daanen, Michael E. Kort |
2011-12-27 |
$25,258,000 |
| 8071762 |
Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor |
Arthur Gomtsyan, Erol K. Bayburt, Chih-Hung Lee, John R. Koenig, Kirill A. Lukin +4 more |
2011-12-06 |
$37,431,000 |
| 8030504 |
Antagonists of the TRPV1 receptor and uses thereof |
Erol K. Bayburt, Jerome F. Daanen, Arthur Gomtsyan, Steven P. Latshaw, Chih-Hung Lee |
2011-10-04 |
$14,101,000 |
| 7998993 |
TRPV1 antagonists |
Richard J. Perner, John R. Koenig, Stanley DiDomenico, Erol K. Bayburt, Jerome F. Daanen +5 more |
2011-08-16 |
$18,160,000 |
| 7812019 |
Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof |
Arthur Gomtsyan, Erol K. Bayburt, Chih-Hung Lee, Brian S. Brown, Tammie K. Jinkerson +3 more |
2010-10-12 |
$27,565,000 |
| 7375126 |
Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor |
Arthur Gomtsyan, Erol K. Bayburt, Chih-Hung Lee, John R. Koenig, Kirill A. Lukin +4 more |
2008-05-20 |
$218,134,000 |
| 7348343 |
Amides useful for treating pain |
Guo Zhu Zheng, Brian S. Brown, Sean Colm Turner, Tammie White, John R. Koenig +1 more |
2008-03-25 |
$191,769,000 |
| 7335678 |
Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1(VR1) receptor |
Chih-Hung Lee, Erol K. Bayburt, Stanley DiDomenico, Irene Drizin, Arthur Gomtsyan +5 more |
2008-02-26 |
$52,480,000 |
| 7129235 |
Amides useful for treating pain |
Guo Zhu Zheng, Brian S. Brown, Sean Colm Turner, Tammie White, John R. Koenig +1 more |
2006-10-31 |
$65,822,000 |
| 7074805 |
Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor |
Chih-Hung Lee, Erol K. Bayburt, Stanley DiDomenico, Irene Drizin, Arthur Gomtsyan +5 more |
2006-07-11 |
$83,073,000 |
| 6933311 |
Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor |
Chih-Hung Lee, Erol K. Bayburt, Stanley DiDomenico, Irene Drizin, Arthur Gomtsyan +5 more |
2005-08-23 |
$125,490,000 |
